Company news

Heartbeam, Inc. news in 2024

Heartbeam, Inc.'s news releases, calls and decks from 2024, newest first.

View company

HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

December 15, 2024

HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference

November 18, 2024

HeartBeam Reports Third Quarter 2024 Results

November 6, 2024

HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4: 30 p.m. Eastern Time

October 30, 2024

HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

October 16, 2024

HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist

September 23, 2024

HeartBeam Names Timothy Cruickshank as Chief Financial Officer

September 9, 2024

HeartBeam Reports Second Quarter 2024 Results

August 13, 2024

HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4: 30 p.m. Eastern Time

July 31, 2024

HeartBeam Added to Russell Microcap® Index

June 30, 2024

HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias

May 19, 2024

HeartBeam Reports First Quarter 2024 Results

May 8, 2024

HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results

March 19, 2024

First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG

March 13, 2024

HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology

March 6, 2024

HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4: 30 p.m. Eastern Time

March 4, 2024

Calls in 2024

Decks in 2024